Changes in left ventricular filling and left atrial function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy

Journal of the American College of Cardiology

Volumn 34, Issue 4, 1999, Pages 1123-1128

  Nagueh, Sherif F ^a   Lakkis, Nasser M ^a   Middleton, Katherine J ^a   Killip, Donna ^a   Zoghbi, William A ^a   Quiñones, Miguel A ^a   Spencer III, William H ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOCARDIOGRAPHY; FEMALE; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FILLING; HEART LEFT VENTRICLE OUTFLOW TRACT OBSTRUCTION; HEART VENTRICLE REMODELING; HEART VENTRICLE SEPTUM; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; TWO DIMENSIONAL ECHOCARDIOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; ATRIAL FUNCTION, LEFT; CARDIAC VOLUME; CARDIOMYOPATHY, HYPERTROPHIC; ECHOCARDIOGRAPHY; ECHOCARDIOGRAPHY, DOPPLER; EXERCISE TEST; FEMALE; FOLLOW-UP STUDIES; HEART SEPTUM; HEMODYNAMIC PROCESSES; HUMANS; MALE; MIDDLE AGED; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0033213580     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(99)00341-1     Document Type: Article

References (22)

1. Sigwart U. Non-surgical myocardial reduction for hypertrophic obstructive cardiomyopathy. Lancet 1995;346:211-4.
2. Knight C, Kurbaan AS, Seggewiss H, et al. Non-surgical septal reduction for hypertrophic obstructive cardiomyopathy: outcome in the first series of patients. Circulation 1997;95:2075-81.
3. Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt H, Strick S. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients. J Am Coll Cardiol 1998;31:252-8.
4. Lakkis NM, Nagueh SF, Kleiman NS, et al. Echocardiography guided ethanol septal reduction for hypertrophic obstructive cardiomyopathy. Circulation 1998;98:1750-5.
5. Nagueh SF, Lakkis NM, Middleton KJ, et al. Changes in left ventricular diastolic function six months after nonsurgical septal reduction therapy for hypertrophic obstructive cardiomyopathy. Circulation 1999;99:344-7.
6. Sasson Z, Yock PG, Hatle LK, Alderman EL, Popp RL. Doppler echocardiographic determination of the pressure gradient in hypertrophic cardiomyopathy. J Am Coll Cardiol 1988;11:752-6.
7. Nagueh SF, Middleton KJ, Kopelen HA, Zoghbi WA, Quinones MA: DTI: a noninvasive technique for evaluation of left ventricular relaxation and estimation of filling pressures. J Am Coll Cardiol 1997;30:1527-33.
8. Kircher B, Abbott JA, Pau S, et al. Left atrial volume determination by biplane two-dimensional echocardiography: validation by cine-computed tomography. Am Heart J 1991;121:864-71.
9. Rokey R, Sterling LL, Zoghbi WA, et al. Determination of regurgitant fraction in isolated mitral or aortic regurgitation by pulsed Doppler two-dimensional echocardiography. J Am Coll Cardiol 1986;7:1273-8.
10. Manning WJ, Silverman DI, Katz SE, Douglas PS. Atrial ejection force: a noninvasive assessment of atrial systolic function. J Am Coll Cardiol 1993;22:221-5.
11. Stefanadis C, Dernellis J, Lambrou S, Toutouzas P. Left atrial energy in normal subjects, in patients with symptomatic mitral stenosis, and in patients with advanced heart failure. Am J Cardiol 1998;82:1220-3.
12. Appleton CP, Galloway JM, Gonzalez MS, Graballa M, Basnight MA. Estimation of left ventricular filling pressures using two-dimensional and Doppler echocardiography in adult patients with cardiac disease. J Am Coll Cardiol 1993;22:1972-82.
13. Nagueh SF, Lakkis NM, Middleton KJ, et al. Doppler estimation of left ventricular filling pressures in patients with hypertrophic cardiomyopathy. Circulation 1999;99:254-61.
14. Wigle ED, Sasson Z, Henderson MA, et al. Hypertrophic cardiomyopathy: the importance of the site and the extent of hypertrophy. A review. Prog Cardiovasc Dis 1985;28:1-83.
15. Bonow RO, Ostrow HG, Rosing DR, et al. Effects of verapamil on left ventricular systolic and diastolic function in patients with hypertrophic cardiomyopathy: pressure-volume analysis with a nonimaging scintillation probe. Circulation 1983;68:1062-73.
16. Bonow RO, Dilsizian V, Rosing DR, Maron BJ, Bacharach SL, Green MV. Verapamil-induced improvement in left ventricular diastolic filling and increased exercise tolerance in patients with hypertrophic cardiomyopathy: short- and long-term effects. Circulation 1985;72:853-64.
17. Maron BJ, Spirito P, Green KJ, Wesley YE, Bonow RO, Arce J. Noninvasive assessment of left ventricular diastolic function by pulsed Doppler echocardiography in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol 1987;10:733-42.
18. Lele SS, Thomson HL, Seo H, Belenkie I, McKenna WJ, Frenneaux MP. Exercise capacity in hypertrophic cardiomyopathy: role of stroke volume limitation, heart rate, and diastolic filling characteristics. Circulation 1995;92:2886-94.
19. Braunwald E, Frahm CJ. Studies on Starling's law of the heart: IV. observations on the hemodynamic functions of the left atrium in man. Circulation 1961;124:633-42.
20. Matsuda Y, Toma Y, Ogawa H, et al. Importance of left atrial function in patients with myocardial infarction. Circulation 1983;67:566-71.
21. Sigwart U, Grbic M, Goy JJ, Kappenberger L. Left atrial function in acute transient left ventricular ischemia produced during percutaneous transluminal coronary angioplasty of the left anterior descending coronary artery. Am J Cardiol 1990;65:282-6.
22. Hoit BD, Shao Y, Gabel M, Walsh RA. In vivo assessment of left atrial contractile performance in normal and pathological conditions using a time-varying elastance model. Circulation 1994;89:1829-38.